- Home
- GIC vs REPL Comparison
GIC vs REPL Comparison
Compare GIC & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIC
- REPL
- Stock Information
- Founded
- GIC 1949
- REPL 2015
- Country
- GIC United States
- REPL United States
- Employees
- GIC N/A
- REPL N/A
- Industry
- GIC Industrial Machinery/Components
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- GIC Industrials
- REPL Health Care
- Exchange
- GIC Nasdaq
- REPL Nasdaq
- Market Cap
- GIC 860.9M
- REPL 851.0M
- IPO Year
- GIC 1995
- REPL 2018
- Fundamental
- Price
- GIC $22.54
- REPL $9.80
- Analyst Decision
- GIC
- REPL Strong Buy
- Analyst Count
- GIC 0
- REPL 6
- Target Price
- GIC N/A
- REPL $20.00
- AVG Volume (30 Days)
- GIC 107.7K
- REPL 682.9K
- Earning Date
- GIC 04-29-2025
- REPL 05-15-2025
- Dividend Yield
- GIC 4.62%
- REPL N/A
- EPS Growth
- GIC N/A
- REPL N/A
- EPS
- GIC 1.58
- REPL N/A
- Revenue
- GIC $1,315,900,000.00
- REPL N/A
- Revenue This Year
- GIC $2.59
- REPL $31.16
- Revenue Next Year
- GIC $4.22
- REPL N/A
- P/E Ratio
- GIC $14.35
- REPL N/A
- Revenue Growth
- GIC 3.27
- REPL N/A
- 52 Week Low
- GIC $22.09
- REPL $4.92
- 52 Week High
- GIC $45.69
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- GIC 40.53
- REPL 28.99
- Support Level
- GIC $22.17
- REPL $10.17
- Resistance Level
- GIC $23.29
- REPL $10.78
- Average True Range (ATR)
- GIC 0.55
- REPL 0.61
- MACD
- GIC 0.04
- REPL -0.11
- Stochastic Oscillator
- GIC 13.10
- REPL 4.84
About GIC Global Industrial Company
Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.